Andra Cīrule

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

Vija Skripconoka, Manfred Danilovitš, Lea Pehme et al. · European Respiratory Journal · 2012 · 336 citations · Full text

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

Florian von Groote-Bidlingmaier, R. F. Patientia, Epifanio Sánchez et al. · The Lancet Respiratory Medicine · 2019 · 161 citations · Full text

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update

Giovanni Battista Migliori, Giovanni Sotgiu, Senia Rosales-Klintz et al. · European Respiratory Journal · 2018 · 85 citations · Full text

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia

Helen R. Stagg, Peter J White, Vija Riekstiņa et al. · Emerging infectious diseases · 2016 · 25 citations · Full text

Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships

Viktorija Ulanova, Agnija Kivrāne, Anda Vīksna et al. · Frontiers in Pharmacology · 2024 · 14 citations · Full text